RE: SBTX12 Jun 2023 19:21
Hi Nick,
LTH here. Nice to see a new name coming to the board with a well researched and well written post. I think it is an interesting and potentially lucrative time to become an investor in SBTX, and in the spirit of your thorough introduction let me share some thoughts which may be helpful to you.
I know a good deal about SBTX, but I do not know of an email address you can write to and get a response as an investor. Not the best start but the truth. Others claim to have had regular responses but I just can’t get through, even trying the Axis customer service line to ask which is the best email to use. They replied saying they would get back to me, but didn’t.
I am also neither a bull or a bear at this moment - I’m not bearish because this company has some really quite amazing science based IP with world changing, mega potential. I’m not bullish because we haven’t had any successes yet so the management are unproven. I’m still here because we only need one success out of our 5 spinning plates (pillars) and the company could easily be worth over £1 a share.
1 - Simple Question.) SA didn’t take the regional licensing offers because he had his eyes on a larger deal with one of a couple of multinationals. The multinationals approached, but wanted to see greater potential from the applications the science is used for, a range of products, if you like. The acne study set to commence this year should assist with this potential, as would an acquisition, as our IP could be linked with a range of creams etc that the acquisition already has on the market. This could lead to one big deal for the whole AxisBiotix ‘pillar’, but all the regional deals were for a minimum of 5 years, so signing one of those would have stood in the way of a larger deal. But we are not expecting a deal imminently.
2.) Already answered.
3.) The acquisition was important for building a product range as mentioned above. It was also said that the addition of the acquisition target had the potential to make the PLC profitable, which is handy for avoiding future raises, however, see answer to 5.
4.) Yes they might.
5.) SA didn’t say the last raise gave him cash for an acquisition, he basically said it strengthened the balance sheet to prepare us for acquisition negotiations. He also said that any acquisition would be subject to further fundraising and/or debt and/or equity.
SA does talk very well, and one would hope that his confidence is justified. If he doesn’t pull off any one of the things he says he will, I’ll feel awfully led on. If he pulls one or more off, I’ll be a very happy investor. Particularly the Croda part, which I would argue is the most likely one to be successful.